VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $256,000 | -42.5% | 2,515 | +1.0% | 0.02% | -52.0% |
| Q3 2015 | $445,000 | -12.6% | 2,491 | +8.7% | 0.05% | -7.4% |
| Q2 2015 | $509,000 | +10.9% | 2,292 | -0.8% | 0.05% | +10.2% |
| Q1 2015 | $459,000 | +97.0% | 2,311 | +41.8% | 0.05% | +96.0% |
| Q4 2014 | $233,000 | +7.4% | 1,630 | -1.6% | 0.02% | 0.0% |
| Q3 2014 | $217,000 | +5.3% | 1,657 | +5.7% | 0.02% | 0.0% |
| Q1 2014 | $206,000 | – | 1,568 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |